Binding thermodynamics and kinetics guided optimization of potent Keap1-Nrf2 peptide inhibitors

被引:43
|
作者
Lu, Meng-Chen [1 ,2 ]
Chen, Zhi-Yun [1 ,2 ]
Wang, Ya-Lou [1 ,2 ]
Jiang, Yong-Lin [1 ,2 ]
Yuan, Zhen-Wei [1 ,2 ]
You, Qi-Dong [1 ,2 ]
Jiang, Zheng-Yu [1 ,2 ,3 ]
机构
[1] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, Jiang Su Key Lab Drug Design & Optimizat, Nanjing 210009, Jiangsu, Peoples R China
[3] China Pharmaceut Univ, Sch Pharm, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R China
来源
RSC ADVANCES | 2015年 / 5卷 / 105期
基金
中国国家自然科学基金;
关键词
PROTEIN-PROTEIN INTERACTION; STRESS-RESPONSE; NRF2; DISCOVERY; PATHWAY; RECOGNITION; INTERFACE; MECHANISM; PROVIDES;
D O I
10.1039/c5ra16262a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Activation of Nrf2 by directly inhibiting the Keap1-Nrf2 Protein-Protein Interaction (PPI) has gained research interest with regard to developing novel agents for treating inflammatory related diseases. In this study, computational methods were used to guide the rational activity improvement of peptide Keap1-Nrf2 inhibitors and to explore the Keap1 binding cavity. Terminal hydrophobic residues and Tyr residue replacements were introduced into the novel peptides. The experimental values of these peptides further confirmed the potential binding sites explored by the MD simulation. Finally, the most promising, peptide 5 with an intracyclic conformation showed a K-d value of 2.8 nM when binding to Keap1 and an IC50 value of 9.4 nM in the Keap1-Nrf2 PPI fluorescence polarization assay. It proved that the active conformation locking strategy is quite useful in Keap1-Nrf2 PPI inhibitor design. It also provided a useful probe to investigate the Keap1-Nrf2 PPI system.
引用
收藏
页码:85983 / 85987
页数:5
相关论文
共 50 条
  • [31] Phenyl Bis-Sulfonamide Keap1-Nrf2 Protein-Protein InteractionInhibitors with an Alternative Binding Mode
    Georgakopoulos, Nikolaos
    Talapatra, Sandeep
    Dikovskaya, Dina
    Naidu, Sharadha Dayalan
    Higgins, Maureen
    Gatliff, Jernrna
    Ayhan, Aysel
    Nikoloudaki, Roxani
    Schaap, Marjolein
    Valko, Klara
    Javid, Farideh
    Dinkova-Kostova, Albena T.
    Kozielski, Frank
    Wells, Geoffrey
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (10) : 7380 - 7398
  • [32] The cytoprotective role of the Keap1-Nrf2 pathway
    Baird, Liam
    Dinkova-Kostova, Albena T.
    ARCHIVES OF TOXICOLOGY, 2011, 85 (04) : 241 - 272
  • [33] Keap1-Nrf2 signalling in pancreatic cancer
    Hayes, Alastair J.
    Skouras, Christos
    Haugk, Beate
    Charnley, Richard M.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2015, 65 : 288 - 299
  • [34] The KEAP1-NRF2 System and Esophageal Cancer
    Hirose, Wataru
    Oshikiri, Hiroyuki
    Taguchi, Keiko
    Yamamoto, Masayuki
    CANCERS, 2022, 14 (19)
  • [35] The KEAP1-NRF2 System and Neurodegenerative Diseases
    Uruno, Akira
    Yamamoto, Masayuki
    ANTIOXIDANTS & REDOX SIGNALING, 2023, 38 (13) : 974 - 988
  • [36] The Keap1-Nrf2 system and diabetes mellitus
    Uruno, Akira
    Yagishita, Yoko
    Yamamoto, Masayuki
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2015, 566 : 76 - 84
  • [37] Monitoring Keap1-Nrf2 interactions in single live cells
    Baird, Liam
    Swift, Sam
    Lleres, David
    Dinkova-Kostova, Albena T.
    BIOTECHNOLOGY ADVANCES, 2014, 32 (06) : 1133 - 1144
  • [38] Structural and mechanistic insights into the Keap1-Nrf2 system as a route to drug discovery
    Madden, Sarah K.
    Itzhaki, Laura S.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2020, 1868 (07):
  • [39] Immunoediting of KEAP1-NRF2 mutant tumours is required to circumvent NRF2-mediated immune surveillance
    Baird, Liam
    Yamamoto, Masayuki
    REDOX BIOLOGY, 2023, 67
  • [40] The KEAP1-NRF2 System as a Molecular Target of Cancer Treatment
    Taguchi, Keiko
    Yamamoto, Masayuki
    CANCERS, 2021, 13 (01) : 1 - 21